Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Validation of Molecular Pathology Codes for the Identification of Mutational Testing in Lung and Colon Cancer.

Medical care - 1 Dec 2017

Vachani Anil, Wong Yu-Ning, Israelite Jennifer, Mitra Nandita, Hin Sakhena, Yang Lin, Smith-McLallen Aaron, Armstrong Katrina, Groeneveld Peter W, Epstein Andrew J

Abstract excerpt

BACKGROUND: Targeted therapy for patients with lung and colon cancer based on tumor molecular profiles is an important cancer treatment strategy, but the impact of gene mutation tests on cancer treatment and outcomes in large populations is not clear. In this study, we assessed the accuracy of an algorithm to identify tumor mutation testing in administrative claims data during a period before test-specific...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Electronic Health Records

Share to Lung Neoplasms

Share to Mutation

Share to Pathology, Molecular

Share to Registries

Source

Open in PubMed Open full text

Identifiers

PMID: 29135776
DOI: 10.1097/MLR.0000000000000484
PMCID: PMC8011835

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Validation of Molecular Pathology Codes for the Identification of Mutational Testing in Lung and Colon Cancer.PMID 29135776Read ↗

Underutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010 - 2013.Semantic proximity Read ↗

Molecular testing patterns in metastatic non-small cell lung cancer.Semantic proximity Read ↗

Improving biomarker testing in advanced non-small-cell lung cancer and metastatic colorectal cancer: experience from a large community oncology network in the USA.Semantic proximity Read ↗

Retrospective Comparison of Operational Metrics Across Diagnostic Approaches for Molecular Testing in Lung and Colon Cancers in a Community-Based Setting.Semantic proximity Read ↗

Temporal trends and regional variability in BRAF and KRAS genetic testing in Denmark (2010-2022): Implications for precision medicine.Semantic proximity Read ↗

Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing.Semantic proximity Read ↗

Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung CancersSemantic proximity Read ↗

Institutional variability in testing for actionable genetic alterations in patients with stage IIIB/C or IV non-small cell lung cancer: A real-world study from the German prospective, observational, multicenter CRISP registry (AIO-TRK-0315).Semantic proximity Read ↗

Epidermal Growth Factor Receptor Mutational Testing and Erlotinib Treatment Among Veterans Diagnosed With Lung Cancer in the United States Department of Veterans Affairs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.